Fundraising Fox
🦊/Companies
Sign in

Surrozen

South San Francisco, US · Founded 2015 · Delaware corporation · 5 known investors

Find your way into Surrozen

Biotech

Founders & leadership

AB
Anna BerkenblitNamed on SEC filing
HV
Harold VarmusNamed on SEC filing

Board

DG
David GoeddelinBoard directorManaging Partner at The Column Group
CPCraig Parker
Craig ParkerBoard directorVenture Partner at The Column Group
TKTim Kutzkey
Tim KutzkeyinBoard directorManaging Partner at The Column Group

Investors · 5

5AM VenturesBoston · $100K – $4M
Horizons VenturesreportedHong Kong · $1M – $110M
The Column Groupreported · 2 sourcesSan Francisco · $30Mvia Tim Kutzkey · board

Also in the syndicate · 2

Euclidian CapitalHartford Healthcare Trust

Reported raises · per SEC filings

Form D private placements

$50M disclosed across 1 round · 2020

▶$50MraisedJun 2020 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anna BerkenblitDirector
  • David GoeddelDirector
  • Harold VarmusDirector
  • Craig ParkerExecutive Officer, Director
  • Tim KutzkeyDirector
Offering amount
$50M
Amount sold
$50M
First sale
Jun 2020
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Surrozen (SRZN) Stock Price Jumps Despite Deepening Losses And Rich Valuation - Simply Wall St Newssimplywall.st · Aug 2026Surrozen (NASDAQ: SRZN) swings to $50.2M profit on Boehringer milestone revenuestocktitan.net · Aug 2026We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Ratefinance.yahoo.com · May 2026Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical TrialsIND Candidates Nominated for the Treatment of Liver Disease and Inflammatory Bowel Disease - BioSpacebiospace.com · Jun 2020Surrozen Raises $50 Million in Series C Financing to Advance Candidates to Human Clinical Trialsglobenewswire.com · Jun 2020Surrozen Raises $50 Million in Series B Financing to Advance Regenerative Antibody Platforms and Liver Disease Candidatesglobenewswire.com · Mar 2019

Frequently asked questions

Who are Surrozen's investors?
Surrozen's investors include 5AM Ventures, Horizons Ventures, The Column Group.
How much funding has Surrozen raised?
Surrozen has disclosed $50M raised across 1 round.
Where is Surrozen headquartered?
Surrozen is headquartered in South San Francisco, US.